Member Exclusive News

New immunomodulatory therapy for cutaneous leishmaniasis

The Syrian conflict has led to a dramatic increase in cases of the parasitic infection cutaneous leishmaniasis. Researchers are developing a novel immunomodulatory analog that may be effective in treating this infection, a study reports.

Go to the profile of Zoe Campbell
Nov 23, 2018

Please sign in or register for FREE

No comments yet.